Journal: Cancers
Article Title: Diallyl Trisulfide Induces ROS-Mediated Mitotic Arrest and Apoptosis and Inhibits HNSCC Tumor Growth and Cancer Stemness.
doi: 10.3390/cancers16020378
Figure Lengend Snippet: Figure 6. DATS administration inhibited the tumor growth of UMSCC-22B cells and cancer stem cells in vivo. (A) Body weights for control mice and those treated with DATS. (B) Representative tumor images of control mice and DATS-treated mice. (C) Average tumor weight in control and DATS-treated mice. In one mouse of the DATS group, the tumor regressed drastically on one side. (D) Average tumor volume as a function of time in control mice and DATS-treated mice (oral gavage administration, five times per week). There were four mice each in the control and DATS treatment group with tumor cells implanted on both the left and right flank of each mouse. (E) Representative images of Ki-67 immunohistochemical staining from control mouse tumor and DATS-treated mouse tumor (magnification ×200, scale bar = 100 µm). (F) Quantification of Ki-67 protein expression. The result shown is the mean H-score (n = 3 for control, and n = 3 for the DATS-treated group). (G) Representative flow histograms for ALDH1 activity from single cells isolated from control and DATS-treated mice tumors. The ALDH1 inhibitor DEAB was used as a control. (H) Quantitation of ALDH1 activity of respective groups. The results shown are mean ± SEM. The p-value was calculated by a two-sided Student’s t-test. DATS, Diallyl trisulfide, p < 0.05 (*), p < 0.0001 (***).
Article Snippet: Diallyl trisulfide Cancers 2024, 16, 378 3 of 19 (DATS, purity > 98%) was procured from LKT Laboratories (St. Paul, MN, USA), and RNase A was sourced from Promega (Madison, WI, USA).
Techniques: In Vivo, Control, Immunohistochemical staining, Staining, Expressing, Activity Assay, Isolation, Quantitation Assay